NCT02824380

Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 14 (actual)
• Sponsor: Dong-A ST Co., Ltd. · Industry
• Sex: Male
• Age: 19 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

An Open-label, Randomized, Multiple-dose, Crossover Study to Evaluate the Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects with Androgenic Alopecia.

Conditions

• Androgenic Alopecia

Interventions

Type	Name	Description
DRUG	DA-4001 H	5% minoxidil / high dose of finasteride
DRUG	DA-4001 L	5% minoxidil / low dose of finasteride

Timeline

• Start date: 2016-07-01
• Primary completion: 2016-10-01
• Completion: 2016-10-01
• First posted: 2016-07-06
• Last updated: 2018-03-30

Locations

1 site across 1 country: South Korea